Table I.
Clinical phenotype of the consented SCD patient population
| Mean ± SE | Range | |
|---|---|---|
| Age | 37.6 ± 2.5 | 19–72 |
| WBC (109/L) | 9.7 ± 0.6 | 4.1–22.6 |
| Reticulocyte count (109/L) | 324.1 ± 29.0 | 89–798 |
| Hemoglobin (g/dL) | 8.8 ± 0.3 | 5.5–12 |
| Platelet count (109/L) | 361.1 ± 22.7 | 155–703 |
| Absolute neutrophil count (106/L) | 4899.1 ± 459.7 | 720–14,240 |
| Lactate dehydrogenase (U/L) | 408.3 ± 32.7 | 157–934 |
| Pain* | 3.4 ± 0.5 | 0–10 |
| Hemoglobin F (%) | 9.8 ± 1.3 | 0.4–23.9 |
| Hemoglobin S (%) | 72.3 ± 3.2 | 17.6–91.1 |
| Hemoglobin A (%) | 10.9 ± 3.2 | 0–66.1 |
Abbreviations: SE, Standard error; WBC, white blood cell.
Data presented is based on 32 blood samples (n) from 27 consented SCD patients (male = 11, female = 16).
*
“n” for pain score was 31.